Skip to search formSkip to main contentSkip to account menu

ponezumab

A humanized monoclonal antibody (IgG2deltaA) raised against amyloid beta peptides with Alzheimer disease treatment application. Ponezumab recognizes… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Antibodies, Monoclonal, Humanized

Narrower (1)

PF-04360365
antigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Unlocking the mystery of Alzheimer ’ s disease : Controversies over hypotheses
he year 2012 represented to be a crucial year for Alzheimer’s disease researchers, with the failure of the two most promising… 
2011
2011
シンポジウム32―3 神経疾患に対する抗体療法 アルツハイマー病に対する抗体療法
In order to avoid Abeta-induced autoimmune encephalitis, several monoclonal and polyclonal antibodies are in clinical trials… 
2011
2011
[Antibody therapy for Alzheimer's disease].
In order to avoid Abeta-induced autoimmune encephalitis, several monoclonal and polyclonal antibodies are in clinical trials… 
2011
2011
A|[beta]|'s dry (AMD) humor
Researchers at Pfizer and Duke have found that immunotherapy against β-amyloid can reverse the retinal protein deposition that… 
2010
2010
Detection of Treatment Effects with 1 H MRS in Transgenic Mouse Model of Alzheimer ’ s Disease
Introduction Drug development studies require sacrificing mice in order to histologically assess therapeutic efficacy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)